{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:57:03Z","timestamp":1790117823833,"version":"4.0.1"},"reference-count":39,"publisher":"Impact Journals, LLC","issue":"34","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,11,3]]},"DOI":"10.18632\/oncotarget.5915","type":"journal-article","created":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T18:03:12Z","timestamp":1445018592000},"page":"36269-36277","source":"Crossref","is-referenced-by-count":32,"title":["Genetic polymorphisms associated with increased risk of developing chronic myelogenous leukemia"],"prefix":"10.18632","volume":"6","author":[{"given":"Heriberto","family":"Bruzzoni-Giovanelli","sequence":"first","affiliation":[{"name":"Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9 UMRS 1160 INSERM, Paris, France"},{"name":"Centre d'Investigations Cliniques 9504 INSERM-AP-HP H\u00f4pital Saint-Louis, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan R.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Centre de Recerca en Epidemiologia Ambiental (CREAL), Barcelona, Spain"},{"name":"Institut Municipal d'Investigaci\u00f3 M\u00e8dica (IMIM), Barcelona, Spain"},{"name":"CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), Spain Centre de Recerca en Epidemiologia Ambiental (CREAL), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Sigaux","sequence":"additional","affiliation":[{"name":"Institut Universitaire d'H\u00e9matologie, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno O.","family":"Villoutreix","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9 UMRS 973 Inserm, Paris, France\/Inserm, U973, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Michel","family":"Cayuela","sequence":"additional","affiliation":[{"name":"Laboratoire Central d'H\u00e9matologie, H\u00f4pital Saint Louis, Paris, France"},{"name":"EA3518, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Guilhot","sequence":"additional","affiliation":[{"name":"Inserm CIC 0802, CHU de Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Preudhomme","sequence":"additional","affiliation":[{"name":"Laboratoire d'H\u00e9matologie, Inserm, U837, CHRU, Lille, France\/Universit\u00e9 de Lille Nord, Institut de Recherche sur le Cancer de Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Guilhot","sequence":"additional","affiliation":[{"name":"Inserm CIC 0802, CHU de Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Poyet","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9 UMRS 1160 INSERM, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rousselot","sequence":"additional","affiliation":[{"name":"Service d'H\u00e9matologie et d'Oncologie, H\u00f4pital Mignot, Universit\u00e9 Versailles, Saint-Quentin-en-Yvelines, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,10,12]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bcmd.2012.06.004","article-title":"Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complications","volume":"49","author":"Najman","year":"2012","journal-title":"Blood Cells Mol Dis"},{"key":"2","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2010.65","article-title":"High-density single nucleotide polymorphism arrayanalysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression","volume":"24","author":"Wainscoat","year":"2010","journal-title":"Leukemia"},{"key":"3","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.leukres.2009.02.025","article-title":"GATA-2L359 V mutation is exclusively associated with CML progression but not other hematological malignancies and GATA-2 P250A is a novel single nucleotide polymorphism","volume":"33","author":"Li","year":"2009","journal-title":"Leuk Res"},{"key":"4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3324\/haematol.2012.066480","article-title":"Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy","volume":"98","author":"Cilloni","year":"2013","journal-title":"Haematologica"},{"key":"5","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/sj.leu.2403935","article-title":"A single nucleotide polymorphism in the coding region of ABL and its effects on sensitivity to imatinib","volume":"19","author":"Deininger","year":"2005","journal-title":"Leukemia"},{"key":"6","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.18632\/oncotarget.1050","article-title":"High imatinib dose overcomes insufficient response associated with ABCG2 haplotype in chronic myelogenous leukemia patients","volume":"4","author":"Bruzzoni-Giovanelli","year":"2013","journal-title":"Oncotarget"},{"key":"7","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1182\/blood-2008-03-147744","article-title":"Multidrug resistance gene (MDR1) polymorphisms are associated with majormolecular responses to standard-dose imatinib in chronic myeloid leukemia","volume":"112","author":"Mahon","year":"2008","journal-title":"Blood"},{"key":"8","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ajh.21726","article-title":"XPC genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemia","volume":"85","author":"Hernandez-Boluda","year":"2010","journal-title":"Am J Hematol"},{"key":"9","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1158\/1078-0432.CCR-09-0145","article-title":"Clinical relevance of a pharmacogenetic approach using multiple candidate genes to predict response and resistance to imatinib therapy in chronic myeloid leukemia","volume":"15","author":"Lipton","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1158\/1078-0432.CCR-10-1638","article-title":"The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia","volume":"16","author":"Lipton","year":"2010","journal-title":"Clin Cancer Res"},{"key":"11","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/annonc\/mdp452","article-title":"Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy","volume":"21","author":"Lipton","year":"2010","journal-title":"Ann Oncol"},{"key":"12","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1182\/blood-2008-07-169110","article-title":"Genetic variants in the candidate genes of the apoptosis pathway and susceptibility to chronic myeloid leukemia","volume":"113","author":"Lipton","year":"2009","journal-title":"Blood"},{"key":"13","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/mc.22061","article-title":"MDM2 promoter polymorphism and p53 codon 72 polymorphism in chronic myeloid leukemia: The association between MDM2 promoter genotype and disease susceptibility, age of onset, and blast-free survival in chronic phase patients receiving imatinib","volume":"53","author":"Lin","year":"2014","journal-title":"Mol Carcinog"},{"key":"14","doi-asserted-by":"crossref","first-page":"8592","DOI":"10.1158\/1078-0432.CCR-05-0039","article-title":"Two single-nucleotide polymorphisms with linkage disequilibrium in the human programmed cell death 5 gene 5\u2032 regulatory region affect promoter activity and the susceptibility of chronic myelogenous leukemia in Chinese population","volume":"11","author":"Zhao","year":"2005","journal-title":"Clin Cancer Res"},{"key":"15","first-page":"12","article-title":"CYP1A1, GST gene polymorphisms and risk of chronic myeloid leukemia","volume":"138","author":"Sunguroglu","year":"2008","journal-title":"Swiss Med Wkly"},{"key":"16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/hon.1018","article-title":"Variations in glutathione-S-transferase genes influence riskof chronic myeloid leukemia","volume":"30","author":"Bosland","year":"2012","journal-title":"Hematol Oncol"},{"key":"17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/CEJ.0b013e3282b72093","article-title":"Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility","volume":"17","author":"Cao","year":"2008","journal-title":"Eur J Cancer Prev"},{"key":"18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.leukres.2009.04.022","article-title":"Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease","volume":"34","author":"Qi","year":"2010","journal-title":"Leuk Res"},{"key":"19","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1007\/s13277-014-2082-y","article-title":"MTHFR gene polymorphism and risk of myeloid leukemia: a meta-analysis","volume":"35","author":"Chen","year":"2014","journal-title":"Tumour Biol"},{"key":"20","doi-asserted-by":"crossref","first-page":"6906","DOI":"10.1182\/blood-2011-01-329797","article-title":"A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia","volume":"117","author":"Jung","year":"2011","journal-title":"Blood"},{"key":"21","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1056\/NEJMoa1004095","article-title":"Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia","volume":"363","author":"Allard","year":"2010","journal-title":"N Engl JMed"},{"key":"22","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/mds.25035","article-title":"Association between Parkinson's disease and the HLA-DRB1 locus","volume":"27","author":"Elbaz","year":"2012","journal-title":"Mov Disord"},{"key":"23","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1086\/429864","article-title":"A note on exact tests of Hardy-Weinberg equilibrium","volume":"76","author":"Abecasis","year":"2005","journal-title":"Am J Hum Genet"},{"key":"24","first-page":"652569","article-title":"Methods for Analyzing Multivariate Phenotypes in Genetic Association Studies","volume":"2012","author":"Wang","year":"2012","journal-title":"J Probab Stat"},{"key":"25","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/sim.4780090710","article-title":"More powerful procedures for multiple significance testing","volume":"9","author":"Benjamini","year":"1990","journal-title":"Stat Med"},{"key":"26","unstructured":"Sinnwell, PaS. haplo.stats: Statistical Analysis of Haplotypes with Traits and Covariates when Linkage Phase is Ambiguous. R package version 1.6.11."},{"key":"27","doi-asserted-by":"crossref","first-page":"W437","DOI":"10.1093\/nar\/gkr391","article-title":"ICSNPathway: identify candidate causal SNPs and pathways from genome-wide association study by one analytical framework","volume":"39","author":"Wang","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"28","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/biomet\/78.3.691","article-title":"A Note on a General Definition of the Coefficient of Determination","volume":"78","author":"Nagelkerke","year":"1991","journal-title":"Biometrika"},{"key":"29","first-page":"644","article-title":"SNPassoc: an R package to perform whole genome association studies","volume":"23","author":"Moreno","year":"2007","journal-title":"Bioinformatics"},{"key":"30","unstructured":"International HapMap Project. Available at: http:\/\/hapmap.ncbi.nlm.nih.gov\/."},{"key":"31","unstructured":"EMBL. 1000 Genomes Project. ftp:\/\/ftp.1000genomes.ebi.ac.uk\/."},{"key":"32","volume-title":"R: Alanguage and environment for statistical computing","author":"R Development Core Team","year":"2008"},{"key":"33","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1038\/ncomms7691","article-title":"Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms","volume":"6","author":"Waghorn","year":"2015","journal-title":"Nat Commun"},{"key":"34","doi-asserted-by":"crossref","first-page":"16121","DOI":"10.1073\/pnas.1305937110","article-title":"Regulation of human hematopoietic stem cell self-renewal by the microenvironment's control of retinoic acid signaling","volume":"110","author":"Jones","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"35","doi-asserted-by":"crossref","first-page":"18099","DOI":"10.1073\/pnas.0507329102","article-title":"Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis","volume":"102","author":"Chan","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"36","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.lungcan.2014.06.014","article-title":"Polymorphisms of peroxisome proliferator-activated receptors and survival of lung cancer and upper aero-digestive tract cancers","volume":"85","author":"Zhang","year":"2014","journal-title":"Lung Cancer"},{"key":"37","first-page":"973","article-title":"Screening for genetic abnormalities involved in ovarian carcinogenesis using retroviral expression libraries","volume":"35","author":"Enomoto","year":"2009","journal-title":"Int J Oncol"},{"key":"38","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.7314\/APJCP.2013.14.11.6399","article-title":"Association of an LMP2 polymorphism with acute myeloid leukemia and multiple myeloma","volume":"14","author":"Oguzkan-Balci","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"39","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1038\/onc.2013.224","article-title":"Coordinated regulation of the immunoproteasome subunits by PML\/RARalpha and PU. 1 in acute promyelocytic leukemia","volume":"33","author":"Wang","year":"2014","journal-title":"Oncogene"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T21:59:04Z","timestamp":1599688744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,12]]},"references-count":39,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2015,11,3]]}},"alternative-id":["5915","26474455"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.5915","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,12]]}}}